Diet and Longevity: What to Eat to Live the Longest, According to Science

1. Introduction: Food as the Most Powerful Longevity Tool

If you could take a single action today that would add years to your life, reduce your risk of heart disease by a third, cut your cancer probability, sharpen your cognitive function into old age, and do it all for free, would you? The action in question is not a drug, not a supplement, not a cutting-edge biohacking protocol. It is simply eating differently.

Of all the modifiable lifestyle factors that influence how long you live, diet occupies a uniquely powerful position. The Global Burden of Disease Study (GBD 2017), which analysed data from 195 countries, concluded that dietary risks accounted for approximately 11 million deaths globally per year, more than tobacco smoking (8 million), high blood pressure (10.4 million), and physical inactivity (3.2 million). Poor diet was the leading risk factor for death worldwide, responsible for roughly one in five deaths across the planet. That statistic alone should command attention.

What makes dietary research particularly compelling for longevity is that the evidence base is enormous. We are not talking about small pilot studies with 20 participants. The studies referenced in this article collectively involve millions of participants, tracked over decades, across diverse populations. The PREDIMED trial enrolled 7,447 people. The Adventist Health Study-2 followed 96,000 participants. The Nurses' Health Study and Health Professionals Follow-Up Study together contributed data from over 200,000 individuals tracked for more than 30 years. The European Prospective Investigation into Cancer and Nutrition (EPIC) enrolled 521,000 participants across ten countries. When findings converge across studies of this magnitude, conducted by independent research groups on different continents using different methodologies, the signal becomes difficult to dismiss.

This article will walk through the evidence on dietary patterns, specific foods, and eating strategies that have been shown to extend human lifespan, or conversely, to shorten it. We will cover the Mediterranean diet, plant-based eating, caloric restriction, intermittent fasting, the specific impact of processed meat, red meat, ultra-processed foods, sugar, fish, nuts, fibre, and a range of individual foods with notable evidence behind them. We will also examine the microbiome, the supplement question, and how Death Clock integrates all of this evidence into its lifespan calculations.

A word on methodology before we begin. Throughout this article, we will prioritise the highest quality evidence available: large randomised controlled trials (RCTs) where they exist, followed by large prospective cohort studies, followed by meta-analyses that pool multiple studies. We will note effect sizes, confidence intervals where relevant, and participant counts. Observational studies have inherent limitations (correlation does not prove causation), and we will flag these. But when the same association appears consistently across multiple study designs, populations, and decades, the totality of evidence carries considerable weight.

Let us begin with the dietary pattern that has accumulated more supporting evidence than any other in the history of nutrition research.

2. The Mediterranean Diet: The Gold Standard

The Mediterranean diet is, by a significant margin, the most thoroughly studied dietary pattern in relation to longevity. Its evidence base spans more than six decades, beginning with Ancel Keys' Seven Countries Study in the 1950s and 1960s, and culminating in the landmark PREDIMED randomised controlled trial in 2013 (republished with corrected randomisation methodology in 2018). No other dietary pattern comes close to this depth of investigation.

What Defines the Mediterranean Diet?

The Mediterranean diet is characterised by high consumption of extra virgin olive oil, vegetables, fruits, legumes, nuts, whole grains, and fish, with moderate consumption of poultry and dairy (particularly fermented dairy such as yoghurt and cheese), and low consumption of red meat, processed meat, and added sugars. Wine is consumed in moderate quantities, typically with meals. Extra virgin olive oil is the primary fat source, replacing butter, margarine, and seed oils.

It is worth noting that the Mediterranean diet is not a single, rigidly defined protocol. It encompasses the traditional eating patterns of multiple countries bordering the Mediterranean Sea, including Greece, southern Italy, Spain, and parts of North Africa. Regional variations exist. What unites them is the emphasis on minimally processed plant foods, olive oil as the dominant fat, and a relative absence of the ultra-processed foods that dominate modern Western diets.

The PREDIMED Trial: The Strongest Evidence

The PREvención con DIeta MEDiterránea (PREDIMED) trial, published in the New England Journal of Medicine, remains the gold standard of dietary intervention research. It was a multicentre randomised controlled trial conducted in Spain between 2003 and 2011, enrolling 7,447 participants aged 55 to 80 who were at high cardiovascular risk but had no existing cardiovascular disease at enrolment.

Participants were randomised into three groups: a Mediterranean diet supplemented with extra virgin olive oil (approximately 1 litre per week), a Mediterranean diet supplemented with mixed nuts (30 grams per day of walnuts, almonds, and hazelnuts), or a control diet (advice to reduce dietary fat). The primary endpoint was a composite of major cardiovascular events: myocardial infarction, stroke, and cardiovascular death.

The results were striking. The Mediterranean diet supplemented with extra virgin olive oil reduced major cardiovascular events by 30% (hazard ratio 0.70, 95% CI 0.54 to 0.92). The Mediterranean diet supplemented with nuts reduced events by 28% (HR 0.72, 95% CI 0.54 to 0.95). These are large effect sizes for a dietary intervention, comparable to or exceeding the effects of some pharmaceutical interventions for cardiovascular prevention.

Beyond the primary endpoint, PREDIMED generated a wealth of secondary findings. The Mediterranean diet groups showed significant reductions in the incidence of type 2 diabetes (52% reduction in the olive oil group), peripheral artery disease, atrial fibrillation, and breast cancer. Cognitive decline was slower in the Mediterranean diet groups. Inflammatory markers (C-reactive protein, interleukin-6) were significantly lower. These broad, multi-system benefits suggest that the Mediterranean diet does not simply target one disease pathway but rather influences fundamental biological processes related to ageing.

Population-Level Lifespan Impact

While PREDIMED measured cardiovascular events rather than total mortality directly, a series of large prospective cohort studies have estimated the lifespan impact of Mediterranean diet adherence. A 2014 meta-analysis by Sofi et al., published in the British Medical Journal, pooled data from 12 prospective cohort studies involving over 1.5 million participants. High adherence to a Mediterranean diet was associated with a 9% reduction in all-cause mortality (RR 0.91, 95% CI 0.89 to 0.94), a 9% reduction in cardiovascular mortality, a 6% reduction in cancer incidence, and a 13% reduction in Parkinson's and Alzheimer's disease incidence.

A 2020 study by Gonzalez-Palacios Torres et al., published in the journal Nutrients, estimated that high adherence to a Mediterranean diet was associated with 4.5 additional years of life expectancy compared to low adherence. A 2022 modelling study by Fadnes et al. in PLOS Medicine, which estimated the impact of sustained dietary changes starting at age 20, projected that an optimised diet (closely resembling the Mediterranean pattern) could add up to 10.7 years of life expectancy for men and 10.4 years for women in the United States, with the largest gains coming from increased legume, whole grain, and nut consumption, and reduced red and processed meat intake. Even starting at age 60, the projected gains were 8.0 years for men and 8.4 years for women.

Mechanisms: Why the Mediterranean Diet Works

The Mediterranean diet appears to influence longevity through multiple biological pathways simultaneously, which likely explains its broad protective effects across many disease categories. The key mechanisms identified in the research literature include the following.

First, anti-inflammatory effects. Chronic low-grade inflammation (sometimes called "inflammageing") is a hallmark of biological ageing and a driver of cardiovascular disease, cancer, neurodegeneration, and metabolic dysfunction. The Mediterranean diet is rich in anti-inflammatory compounds, including the polyphenols in extra virgin olive oil (particularly oleocanthal and hydroxytyrosol), the flavonoids in fruits and vegetables, and the omega-3 fatty acids in fish and nuts. PREDIMED substudy data showed significant reductions in C-reactive protein, interleukin-6, and other inflammatory biomarkers.

Second, antioxidant protection. The diet provides an extraordinarily high intake of dietary antioxidants from vegetables, fruits, olive oil, nuts, and wine. These compounds neutralise reactive oxygen species (ROS) that damage DNA, proteins, and lipids, contributing to cellular ageing.

Third, improved lipid profiles. The Mediterranean diet reduces LDL cholesterol, triglycerides, and the ratio of total to HDL cholesterol, all established risk factors for atherosclerotic cardiovascular disease. The monounsaturated fatty acids in olive oil are particularly effective at improving lipid profiles.

Fourth, insulin sensitivity. The diet's emphasis on whole grains, legumes, vegetables, and healthy fats (rather than refined carbohydrates) improves glycaemic control and insulin sensitivity, reducing the risk of type 2 diabetes, which is itself a major driver of accelerated ageing and early death.

Fifth, telomere preservation. A 2014 study by Crous-Bou et al. in the BMJ found that greater adherence to the Mediterranean diet was associated with longer telomeres in the Nurses' Health Study cohort (4,676 women). Telomere length is a biomarker of biological ageing, and this association suggests the diet may slow cellular ageing at a fundamental level.

Sixth, gut microbiome modulation. The Mediterranean diet's high fibre content and diversity of plant foods promotes a diverse gut microbiome enriched in beneficial species that produce short-chain fatty acids (SCFAs), which have anti-inflammatory and metabolic benefits. We will explore this microbiome connection in more detail in a later section.

3. Plant-Based Diets and Mortality

The question of whether avoiding animal products extends lifespan has generated passionate debate, both in the scientific community and in popular culture. The evidence, while not as clean as a single large RCT, is substantial and largely consistent: plant-based diets are associated with reduced mortality, though the details matter enormously.

The Adventist Health Study-2

The most informative study on this question is the Adventist Health Study-2 (AHS-2), a prospective cohort study of 96,469 Seventh-day Adventist church members in the United States and Canada, initiated in 2002. Adventists are an ideal population for studying diet and longevity because the community includes a wide range of dietary patterns (from vegan to regular meat-eaters) within a population that shares similar lifestyle factors (most Adventists do not smoke, many abstain from alcohol, and physical activity levels are relatively uniform). This natural variation allows researchers to isolate the effect of diet more cleanly than in the general population.

The key mortality findings from AHS-2, published by Orlich et al. in JAMA Internal Medicine in 2013, showed that compared to non-vegetarians, all-cause mortality was significantly lower in vegetarians. Specifically:

The pesco-vegetarian group (those who ate fish but no other meat) showed the strongest mortality benefit at 19% lower all-cause mortality. This is a notable finding: it suggests that adding fish to a plant-heavy diet may be more protective than strict veganism, potentially due to the omega-3 fatty acids and other nutrients fish provides.

The overall vegetarian group (combining all vegetarian subtypes) had a 12% lower risk of all-cause mortality (HR 0.88, 95% CI 0.80 to 0.97). When stratified by sex, the benefit was more pronounced in men (HR 0.82) than in women (HR 0.93).

Other Large Cohort Evidence

The EPIC-Oxford study, which followed 65,000 participants in the United Kingdom, found a 12% lower risk of all-cause mortality in vegetarians and vegans compared to meat-eaters, but this did not reach statistical significance after adjusting for body mass index (HR 0.88, 95% CI 0.77 to 1.02). However, specific disease outcomes were significant: vegetarians had a 32% lower risk of ischaemic heart disease (HR 0.68, 95% CI 0.58 to 0.81).

A 2016 meta-analysis by Dinu et al. in Critical Reviews in Food Science and Nutrition pooled data from multiple cohorts and found that vegetarian diets were associated with a 25% reduction in ischaemic heart disease incidence and mortality (RR 0.75, 95% CI 0.68 to 0.82) and an 8% reduction in cancer incidence (RR 0.92, 95% CI 0.87 to 0.98).

Quality of Plant-Based Diet Matters

A critical insight from recent research is that not all plant-based diets are equal. A 2017 study by Satija et al. in the Journal of the American College of Cardiology, using data from 209,298 participants in three large Harvard cohorts (Nurses' Health Study, Nurses' Health Study 2, and Health Professionals Follow-up Study), created two indices: a healthy plant-based diet index (emphasising whole grains, fruits, vegetables, nuts, legumes, and healthy oils) and an unhealthy plant-based diet index (emphasising fruit juices, refined grains, potatoes, sugar-sweetened beverages, and sweets).

The results were stark. A higher score on the healthy plant-based diet index was associated with significantly lower all-cause mortality (HR 0.75, comparing highest to lowest quintile), while a higher score on the unhealthy plant-based diet index was associated with higher mortality (HR 1.23). In other words, a diet of chips, white bread, fizzy drinks, and sweets is technically plant-based but will shorten your life, not extend it. The protective effect comes from the quality of plant foods consumed, not merely the absence of animal products.

The Blue Zones Perspective

The Blue Zones research by Dan Buettner identified five populations with unusually high concentrations of centenarians: Okinawa (Japan), Sardinia (Italy), Nicoya (Costa Rica), Ikaria (Greece), and Loma Linda, California (the Adventist community). While these populations eat different specific foods, their diets share common features: they are predominantly plant-based (approximately 95% of calories from plants in most Blue Zones), rich in legumes, whole grains, and vegetables, low in processed food and added sugar, and moderate in total caloric intake. Meat is consumed rarely and in small portions, typically as a condiment rather than a centrepiece.

The Okinawan diet is particularly instructive. Traditional Okinawans derived approximately 67% of their calories from sweet potatoes, with the remainder coming from soy (particularly tofu and miso), green vegetables, and small amounts of fish and pork. Their caloric intake was approximately 1,800 calories per day, roughly 20% less than the Japanese mainland average. Okinawa had the highest life expectancy and the highest concentration of centenarians in the world until Westernisation of the diet began in the 1960s, after which rates of obesity, diabetes, and premature mortality increased dramatically, particularly among younger generations.

4. Caloric Restriction: Eating Less to Live Longer

Caloric restriction (CR), defined as a sustained reduction in caloric intake (typically 20 to 40%) below ad libitum levels without malnutrition, is the most robustly demonstrated intervention for extending lifespan in laboratory organisms. It extends lifespan in yeast, worms, flies, mice, rats, and possibly primates. Whether it extends human lifespan remains an open question, but the evidence is sufficient to warrant serious attention.

Animal Evidence: The Foundation

The caloric restriction story began in 1935, when Clive McCay at Cornell University demonstrated that rats fed a calorie-restricted diet lived up to 33% longer than rats fed ad libitum. This finding has been replicated hundreds of times across species. In mice, caloric restriction of 30 to 40% consistently extends median lifespan by 20 to 50%, delays the onset of age-related diseases (cancer, kidney disease, cardiovascular disease, neurodegeneration), and preserves youthful physiological function.

The primate data is where the story becomes most relevant to humans. Two long-running studies in rhesus monkeys produced seemingly contradictory results that, on closer examination, actually converge.

The University of Wisconsin study (Colman et al., Science, 2009, with updated data published in Nature Communications, 2014) began in 1989 with 76 rhesus monkeys. Animals in the CR group received 30% fewer calories than the control group. After 20 years of follow-up, the CR monkeys had a threefold reduction in age-related disease and a significant survival advantage. Mortality from age-related causes was 63% lower in the CR group (p = 0.008). The CR monkeys looked visibly younger, had less grey hair, less muscle wasting, and maintained more youthful body composition.

The National Institute on Aging (NIA) study (Mattison et al., Nature, 2012, updated 2017) began in 1987 with 121 monkeys. This study initially reported no significant survival benefit from CR. However, several critical methodological differences explain the apparent discrepancy. The NIA control animals were fed a controlled, portioned diet (not truly ad libitum), so they were leaner and consumed fewer calories than typical captive monkeys. Additionally, the NIA study started CR in some animals when they were very young (juveniles), while the Wisconsin study began CR in adults. When the data from both studies were combined and reanalysed in a 2017 collaborative paper (Mattison et al., Nature Communications), the authors concluded that caloric restriction does indeed improve health and survival in primates, with the strongest benefits observed when CR is initiated in adulthood.

The CALERIE Trial: Caloric Restriction in Humans

The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trial is the only long-term randomised controlled trial of caloric restriction in non-obese humans. CALERIE Phase 2, published by Ravussin et al. in the Lancet Diabetes and Endocrinology in 2015, randomised 218 healthy, non-obese adults (aged 21 to 50) to either 25% caloric restriction or an ad libitum control diet for two years.

In practice, participants in the CR group achieved an average of approximately 12% caloric restriction (not the targeted 25%), which is important context for interpreting the results. Even at this modest level of restriction, the findings were notable. The CR group lost an average of 7.5 kg of body weight (most of it fat). Fasting insulin decreased by 30.4%. Core body temperature decreased (a biomarker associated with longevity in animal models). Thyroid hormone (T3) decreased by 15.4%, consistent with a lower metabolic rate. Tumour necrosis factor-alpha (an inflammatory marker) decreased significantly. Importantly, there were no adverse effects on bone density, mood, sexual function, or quality of life at the levels of CR achieved.

A 2023 follow-up analysis of CALERIE data by Waziry et al. in Nature Aging used the DunedinPACE biological ageing clock to measure the pace of biological ageing. The CR group showed a 2 to 3% slowing of the pace of biological ageing, which the authors estimated would translate to a 10 to 15% reduction in mortality risk, comparable to the effect of quitting smoking. This is the strongest direct evidence to date that caloric restriction slows biological ageing in humans.

The Okinawan Example

The traditional Okinawan population provides perhaps the best real-world example of mild caloric restriction in a human population. Traditional Okinawans practiced a cultural norm called "hara hachi bu," which translates roughly to "eat until you are 80% full." Their estimated caloric intake was approximately 1,800 calories per day, roughly 10 to 15% below their estimated energy requirements and well below the caloric intake of mainland Japanese (approximately 2,200 calories) or Americans (approximately 2,500 calories at the time).

The results speak for themselves. Okinawa had the highest verified centenarian rate in the world (approximately 50 per 100,000 population, compared to the US rate of approximately 20 per 100,000). Rates of cardiovascular disease were 80% lower than the US. Rates of breast and prostate cancer were 75% lower. The leading causes of death in the West (heart disease, cancer, stroke) occurred at dramatically lower rates and at much older ages.

Practical Implications: Caloric Restriction Without Deprivation

Few people will sustain 30% caloric restriction for decades. The CALERIE data suggests that even modest restriction (10 to 15%) produces measurable biological benefits. There are several approaches to achieving mild caloric restriction without the misery of chronic hunger. These include focusing on nutrient-dense, low-calorie-density foods (vegetables, fruits, legumes, whole grains), which fill the stomach with fewer calories. Using smaller plates and bowls, which has been shown in behavioural research to reduce intake by 10 to 15% without conscious effort. Practising the Okinawan "hara hachi bu" principle of stopping before feeling completely full. Reducing energy-dense but nutrient-poor foods (refined grains, added sugars, processed snacks), which contribute calories without satiety. Time-restricted eating, which we will discuss next, also tends to produce a modest caloric deficit naturally.

5. Intermittent Fasting: Separating Hype from Evidence

Intermittent fasting (IF) has become one of the most popular dietary trends of the past decade, fuelled by enthusiastic media coverage, bestselling books, and a growing body of animal research. The claims are dramatic: extended lifespan, reduced cancer risk, improved brain function, enhanced autophagy (cellular self-cleaning), and metabolic rejuvenation. Some of these claims have strong support in animal models. The critical question is what the human evidence actually shows.

Types of Intermittent Fasting

Several distinct protocols fall under the intermittent fasting umbrella. Time-restricted eating (TRE) involves consuming all food within a limited daily window, typically 8 to 10 hours (the "16:8" pattern being most popular, with 16 hours of fasting and 8 hours of eating). The 5:2 protocol involves eating normally for five days per week and restricting intake to 500 to 600 calories on two non-consecutive days. Alternate-day fasting (ADF) involves alternating between normal eating days and fasting days (either complete fasting or consuming 500 calories). Prolonged fasting involves fasting for 24 to 72 hours or longer, typically done infrequently.

Animal Evidence: Impressive but Context-Dependent

In rodent studies, intermittent fasting extends lifespan by 10 to 30%, depending on the protocol, strain, and sex of the animals. A landmark 2019 study by de Cabo and Mattson, published in the New England Journal of Medicine, reviewed the animal literature and identified several key mechanisms: improved glucose regulation, increased stress resistance, activation of autophagy (the cellular recycling process), reduced inflammation, and enhanced DNA repair. These are precisely the pathways implicated in ageing.

However, the animal evidence has important caveats. Most studies are in male mice. The benefits of IF in animals are often confounded by caloric restriction (fasting animals tend to eat less overall, even when food is freely available during eating windows). When calories are carefully matched between IF and ad libitum groups, the independent benefit of fasting timing is smaller, though still present in some studies. And rodent metabolism differs substantially from human metabolism in ways that affect fasting physiology.

Human RCT Evidence: What We Actually Know

The human evidence for intermittent fasting is growing but remains limited in terms of long-term, hard endpoints (mortality, cardiovascular events, cancer incidence). Most human RCTs have been short-term (12 weeks to 12 months) and have measured intermediate outcomes (weight, blood markers, insulin sensitivity) rather than lifespan. Here is what the best human studies show.

For time-restricted eating (16:8), a 2022 randomised trial by Liu et al. in the New England Journal of Medicine enrolled 139 obese participants in China and compared time-restricted eating (eating only between 8am and 4pm) with calorie-matched controls for 12 months. The result: no significant difference in weight loss, body fat, metabolic markers, or any measured outcome between the two groups when calories were equal. This suggests that the benefit of TRE may be primarily through reducing overall caloric intake rather than through the fasting window itself.

Conversely, a 2023 systematic review by Moon et al. in the journal Nutrients, which pooled 23 human RCTs of time-restricted eating, found modest but consistent benefits for body weight reduction (weighted mean difference of approximately 1.6 kg), fasting glucose, and insulin resistance. Most of these trials did not control for caloric intake, suggesting the caloric deficit created by a shorter eating window explains much of the benefit.

For alternate-day fasting, a 2019 randomised trial by Stekovic et al. in Cell Metabolism (the "InterFAST" trial) enrolled 60 healthy, non-obese adults and randomised them to alternate-day fasting or ad libitum eating for four weeks, with a follow-up observational group that had practiced ADF for over six months. The ADF group showed reduced body weight, improved cardiovascular markers (reduced LDL cholesterol, reduced heart rate), reduced inflammatory markers (reduced sICAM-1), and reduced levels of the age-associated protein triiodothyronine (T3). The six-month observational group showed similar benefits without adverse effects.

For the 5:2 protocol, a 2018 randomised trial by Sundfor et al. in the British Journal of Nutrition compared the 5:2 diet with daily caloric restriction in 112 participants for six months. Both groups lost similar amounts of weight and showed similar improvements in metabolic markers. No significant advantage of the 5:2 pattern was observed over simple daily caloric restriction.

The Bottom Line on Intermittent Fasting

The honest summary of the human evidence as of 2026 is this: intermittent fasting is a safe and effective strategy for reducing caloric intake and losing weight in many people. It produces modest improvements in insulin sensitivity, inflammatory markers, and cardiovascular risk factors. There is no long-term human RCT demonstrating lifespan extension from any form of intermittent fasting. The dramatic longevity claims made in popular media are extrapolated from animal data and should be treated as hypotheses, not established facts. That said, if intermittent fasting helps you maintain a healthy weight and eat less processed food, it is a reasonable approach. The best diet is the one you can sustain.

6. Processed Meat: A Group 1 Carcinogen on Your Plate

In October 2015, the International Agency for Research on Cancer (IARC), a specialised agency of the World Health Organisation, classified processed meat as a Group 1 carcinogen, meaning there is sufficient evidence that it causes cancer in humans. This places processed meat in the same classification category as tobacco smoking, asbestos, and ionising radiation. The distinction is important: this does not mean processed meat is as dangerous as smoking (it is not), but it does mean the evidence that it causes cancer is equally convincing.

What Counts as Processed Meat?

Processed meat is defined by IARC as meat that has been transformed through salting, curing, fermentation, smoking, or other processes to enhance flavour or improve preservation. Common examples include bacon, sausages, hot dogs, ham, salami, corned beef, beef jerky, canned meat, and deli meats (such as turkey breast or roast beef that has been processed). The key carcinogenic agents in processed meat include N-nitroso compounds (formed during curing with nitrites and nitrates), polycyclic aromatic hydrocarbons (formed during smoking), and heterocyclic amines (formed during high-temperature cooking).

The Cancer Evidence

The IARC classification was based on a review of over 800 epidemiological studies from multiple countries. The strongest evidence concerned colorectal cancer. A 2011 meta-analysis by Chan et al. for the World Cancer Research Fund, which pooled data from 10 prospective cohort studies, found that each 50-gram daily serving of processed meat (approximately two slices of bacon or one hot dog) was associated with an 18% increased risk of colorectal cancer (RR 1.18, 95% CI 1.10 to 1.28). This dose-response relationship was linear, with no apparent threshold below which processed meat was safe.

Beyond colorectal cancer, processed meat consumption has been associated with increased risk of stomach cancer (particularly non-cardia gastric cancer), pancreatic cancer, and breast cancer, though the evidence for these is less definitive than for colorectal cancer.

The Mortality Evidence

The impact of processed meat extends well beyond cancer. A 2013 study in the EPIC cohort (Rohrmann et al., BMC Medicine) followed 448,568 men and women across ten European countries. High processed meat consumption (more than 160 grams per day) was associated with a 44% higher risk of all-cause mortality (HR 1.44, 95% CI 1.24 to 1.66) compared to low consumption (10 to 19.9 grams per day). Cardiovascular mortality was increased by 72% (HR 1.72, 95% CI 1.29 to 2.29) and cancer mortality by 11% (HR 1.11, 95% CI 0.88 to 1.40). The authors estimated that 3.3% of all deaths in the study population could be prevented if processed meat consumption were reduced to less than 20 grams per day.

A 2017 meta-analysis by Schwingshackl et al. in the European Journal of Epidemiology pooled dose-response data from multiple large cohorts and found that each 50-gram per day increase in processed meat consumption was associated with a 23% increase in cardiovascular disease mortality (RR 1.23, 95% CI 1.12 to 1.36) and a 8% increase in all-cause mortality (RR 1.08, 95% CI 1.01 to 1.16). The cardiovascular risk is thought to be driven by the high sodium content, the formation of trimethylamine N-oxide (TMAO) from carnitine and choline in the gut, and the nitrite-derived compounds that impair endothelial function.

In terms of lifespan, modelling studies estimate that eliminating processed meat from the diet could add approximately 1 to 2 years of life expectancy, depending on baseline consumption levels. The 2022 Fadnes et al. modelling study in PLOS Medicine estimated that reducing processed meat consumption from typical Western levels to zero could add approximately 1.6 years of life expectancy for men and 1.5 years for women when the change is made at age 20.

7. Red Meat: The Nuanced Evidence

The evidence on unprocessed red meat (beef, pork, lamb, veal, mutton) is more nuanced than the evidence on processed meat. While IARC classified red meat as a Group 2A carcinogen ("probably carcinogenic to humans"), the epidemiological data shows a smaller and more uncertain risk than for processed meat, and the picture is complicated by the heterogeneity of red meat consumption patterns across populations.

The Large Cohort Data

The most comprehensive analysis of red meat and mortality was published by Zheng et al. in the BMJ in 2019. This study analysed data from 53,553 women in the Nurses' Health Study and 27,916 men in the Health Professionals Follow-Up Study, with up to 32 years of follow-up during which 14,019 deaths occurred, accounting for approximately 81,000 person-years of follow-up among those who died. The authors examined changes in red meat consumption over time and their subsequent association with mortality.

The findings showed that increasing red meat consumption by at least half a serving per day over an 8-year period was associated with a 10% higher risk of all-cause mortality over the subsequent 8 years (HR 1.10, 95% CI 1.04 to 1.17). The association was stronger for processed red meat (HR 1.13, 95% CI 1.04 to 1.23) than for unprocessed red meat (HR 1.09, 95% CI 1.02 to 1.17). Importantly, decreasing red meat consumption by at least half a serving per day was associated with a 6% lower risk of mortality. When participants replaced one serving of red meat with an equivalent serving of fish, poultry, nuts, legumes, or whole grains, mortality risk decreased by 8 to 17%, depending on the substitute.

An earlier 2012 analysis from the same cohorts by Pan et al. in the Archives of Internal Medicine found that one additional serving of unprocessed red meat per day was associated with a 13% higher risk of all-cause mortality (HR 1.13, 95% CI 1.07 to 1.20), and one additional serving of processed red meat per day was associated with a 20% higher risk (HR 1.20, 95% CI 1.15 to 1.24). Over the study period, the authors estimated that 9.3% of deaths in men and 7.6% of deaths in women could have been prevented if all participants had consumed fewer than 0.5 servings of red meat per day.

The Counterargument: The NutriRECS Controversy

In 2019, a group of researchers published the NutriRECS guidelines in the Annals of Internal Medicine (Johnston et al.), which concluded that adults could continue current levels of red and processed meat consumption, rating the evidence for reducing intake as "low to very low certainty." This generated enormous controversy. The NutriRECS panel used a different methodology (the GRADE framework, which prioritises randomised trials and tends to rate observational evidence as low quality) and placed greater weight on the small absolute risk reduction and the value people place on eating meat.

The reaction from the nutrition research community was swift and critical. The Harvard T.H. Chan School of Public Health, the American Heart Association, the American Cancer Society, and the World Cancer Research Fund all publicly disagreed with the NutriRECS conclusions. Critics argued that the panel applied an inappropriate methodological framework (designed for drug trials) to nutritional epidemiology, where randomised trials of dietary patterns and mortality are impractical. The controversy highlighted a genuine tension in evidence-based medicine: how to weigh consistent observational evidence across millions of participants when randomised trial data is unavailable.

Mechanisms of Harm

Several biological mechanisms link red meat consumption to disease and mortality. Haem iron, which is abundant in red meat and highly bioavailable, catalyses the formation of N-nitroso compounds in the gut and promotes oxidative stress. Elevated iron stores have been independently associated with increased risk of type 2 diabetes, cardiovascular disease, and certain cancers. TMAO production from carnitine and choline (abundant in red meat) by gut bacteria is associated with atherosclerosis. Heterocyclic amines and polycyclic aromatic hydrocarbons formed during high-temperature cooking of meat are mutagenic. Saturated fat content, while the subject of ongoing debate, may contribute to cardiovascular risk in the context of high overall consumption.

Practical Takeaway

The evidence does not support the claim that moderate red meat consumption (2 to 3 servings per week of unprocessed red meat) is a major health hazard for most individuals. It does support the claim that high consumption (daily servings, especially of processed red meat) increases the risk of colorectal cancer, cardiovascular disease, type 2 diabetes, and all-cause mortality. The most impactful change is not necessarily eliminating red meat entirely but rather reducing consumption of processed meat, limiting unprocessed red meat to a few servings per week, and replacing the displaced calories with fish, nuts, legumes, or whole grains.

8. Ultra-Processed Foods and Early Death

The concept of ultra-processed foods (UPFs), defined by the NOVA classification system developed by Carlos Monteiro and colleagues at the University of Sao Paulo, has transformed how nutritional researchers think about diet and disease. The NOVA system classifies foods into four groups based on the degree and purpose of processing, rather than their nutrient content.

Group 1 consists of unprocessed or minimally processed foods (fruits, vegetables, meat, fish, eggs, grains, milk). Group 2 consists of processed culinary ingredients (oils, butter, sugar, salt, flour). Group 3 consists of processed foods made by combining groups 1 and 2 (cheese, canned vegetables, freshly baked bread, cured meats). Group 4 consists of ultra-processed food and drink products, which are industrial formulations made mostly or entirely from substances derived from foods and additives, with little or no intact food. Examples of UPFs include soft drinks, packaged snacks, mass-produced breads, sweetened breakfast cereals, reconstituted meat products (nuggets, fish fingers), instant noodles, frozen ready meals, and confectionery.

The NutriNet-Sante Study

The most cited study on ultra-processed foods and mortality is the NutriNet-Sante cohort study from France. Schnabel et al., published in JAMA Internal Medicine in 2019, followed 44,551 French adults (aged 45 and older) for a median of 7.1 years. They found that a 10 percentage point increase in the proportion of UPFs in the diet was associated with a 14% increase in all-cause mortality (HR 1.14, 95% CI 1.04 to 1.27). The median proportion of UPFs in participants' diets was 14.4% by weight, but ranged from 7.5% in the lowest quartile to 22.6% in the highest quartile. Those in the highest quartile of UPF consumption had significantly higher mortality than those in the lowest quartile, even after adjusting for overall diet quality, BMI, physical activity, smoking, and socioeconomic factors.

A companion analysis from the same cohort by Fiolet et al., published in the BMJ in 2018, found that a 10% increase in UPF consumption was associated with a 12% increase in overall cancer risk (HR 1.12, 95% CI 1.06 to 1.18) and an 11% increase in breast cancer risk (HR 1.11, 95% CI 1.02 to 1.22).

Corroborating Evidence from Other Cohorts

The NutriNet-Sante findings have been replicated in multiple large cohorts. A 2019 study by Rico-Campa et al. in the BMJ followed 19,899 Spanish university graduates for a median of 10.4 years and found that consumption of more than 4 servings of UPFs per day was associated with a 62% higher hazard of all-cause mortality compared to fewer than 2 servings per day (HR 1.62, 95% CI 1.13 to 2.33). Each additional daily serving of UPFs was associated with an 18% increase in mortality (HR 1.18, 95% CI 1.05 to 1.33).

A 2022 study by Bonaccio et al. in the BMJ used data from the Moli-sani cohort (22,895 Italian adults) and found that high UPF consumption was associated with increased all-cause mortality (HR 1.19, 95% CI 1.05 to 1.36 for the highest vs. lowest quartile) and cardiovascular mortality (HR 1.27, 95% CI 1.01 to 1.60). Importantly, this study showed that the harmful association of UPFs was independent of the nutritional quality of the overall diet, suggesting that something about ultra-processing itself, beyond the nutrient profile, contributes to the harm.

A 2024 meta-analysis by Lane et al. in the BMJ pooled data from 45 unique pooled analyses involving nearly 10 million participants and found consistent associations between higher UPF consumption and increased risk of all-cause mortality (RR 1.14, 95% CI 1.06 to 1.22), cardiovascular disease mortality, type 2 diabetes, depression, anxiety, and sleep disorders.

Why Are Ultra-Processed Foods Harmful?

Multiple hypotheses have been proposed for why UPFs are harmful beyond their often poor nutritional profile (high in sugar, salt, unhealthy fats, and low in fibre, vitamins, and minerals). First, the industrial additives used in UPFs (emulsifiers, artificial sweeteners, flavour enhancers, preservatives, colourants) may have direct harmful effects. For example, emulsifiers such as carboxymethylcellulose and polysorbate-80 have been shown in animal studies to disrupt the gut mucosal barrier, promote gut inflammation, and alter the microbiome in ways that promote metabolic syndrome. Second, the physical structure of UPFs (highly processed, often soft, requiring little chewing) leads to faster eating speed and reduced satiety, promoting overconsumption. A landmark 2019 randomised crossover trial by Hall et al. at the National Institutes of Health found that participants consumed approximately 500 more calories per day when offered an ultra-processed diet compared to an unprocessed diet, even when the two diets were matched for macronutrient composition, fibre, sugar, and sodium. The UPF diet led to weight gain of approximately 0.9 kg over just two weeks, while the unprocessed diet led to weight loss of 0.9 kg. Third, UPFs may displace healthier foods from the diet. Fourth, the high glycaemic load of many UPFs promotes insulin resistance and metabolic dysfunction.

In many industrialised countries, UPFs now constitute 50 to 60% of total caloric intake. In the United States, the figure is approximately 57% (Juul et al., American Journal of Clinical Nutrition, 2022). In the United Kingdom, it is approximately 56.8%. Given the dose-response relationship between UPF consumption and mortality, this represents a population-level health crisis that rivals tobacco in its potential for harm.

9. Sugar: The Metabolic Damage Pathway

Added sugar, particularly in the form of sugar-sweetened beverages (SSBs), is one of the most clearly established dietary risk factors for premature death. The mechanisms are well-characterised, the epidemiological data is enormous, and the dose-response relationship is robust.

Sugar-Sweetened Beverages and Mortality

A 2019 study by Malik et al. in Circulation pooled data from 80,647 women in the Nurses' Health Study and 37,716 men in the Health Professionals Follow-up Study over 28 to 34 years of follow-up. Consumption of 2 or more sugar-sweetened beverages per day was associated with a 21% higher risk of all-cause mortality (HR 1.21, 95% CI 1.13 to 1.28) compared to less than one per month. The association was driven primarily by cardiovascular disease mortality (31% higher risk, HR 1.31, 95% CI 1.15 to 1.50) and to a lesser extent cancer mortality (16% higher risk, HR 1.16, 95% CI 1.04 to 1.29). Each additional serving per day was associated with a 7% higher risk of all-cause mortality and an 10% higher risk of cardiovascular mortality.

These findings have been replicated globally. A 2023 meta-analysis by Qin et al. in the BMJ pooled data from 39 prospective cohort studies involving over 4 million participants and found that each additional 250 ml per day of SSBs was associated with a 4% increase in all-cause mortality (RR 1.04, 95% CI 1.01 to 1.07), a 8% increase in cardiovascular mortality, and a 2% increase in cancer mortality.

The Metabolic Damage Pathway

Robert Lustig and colleagues have described what they term the "metabolic damage pathway" of excess sugar consumption, particularly fructose. When consumed in large quantities (as in SSBs and processed foods), fructose is metabolised almost exclusively by the liver, where it promotes de novo lipogenesis (the creation of new fat), leading to hepatic steatosis (fatty liver). This, in turn, drives hepatic insulin resistance, hyperinsulinaemia, dyslipidaemia (elevated triglycerides, reduced HDL cholesterol, small dense LDL particles), visceral adiposity, and systemic inflammation. The end result is a cluster of metabolic derangements collectively known as metabolic syndrome, which dramatically increases the risk of type 2 diabetes, cardiovascular disease, and premature death.

A 2010 meta-analysis by Malik et al. in Diabetes Care found that individuals consuming 1 to 2 SSBs per day had a 26% greater risk of developing type 2 diabetes (RR 1.26, 95% CI 1.12 to 1.41) compared to those consuming less than 1 per month. A separate meta-analysis found that each additional SSB per day was associated with a 15% increase in coronary heart disease risk (Fung et al., Circulation, 2009).

Beyond SSBs, total added sugar intake has been associated with mortality in a dose-response manner. Yang et al. in JAMA Internal Medicine (2014) analysed NHANES data and found that participants who consumed 25% or more of their calories from added sugar had a 2.75-fold increase in cardiovascular mortality (HR 2.75, 95% CI 1.40 to 5.42) compared to those who consumed less than 10% of calories from added sugar. Even moderate consumption (10 to 24.9% of calories from added sugar) was associated with a 30% higher risk (HR 1.30, 95% CI 1.09 to 1.55).

Advanced Glycation End Products (AGEs)

Excess sugar consumption also accelerates the formation of advanced glycation end products (AGEs), which are formed when sugars react non-enzymatically with proteins, lipids, and nucleic acids. AGEs accumulate with age and are directly implicated in the pathology of diabetes complications, cardiovascular disease, Alzheimer's disease, and kidney disease. They cross-link collagen and other structural proteins, contributing to arterial stiffness and tissue ageing. They activate the receptor for AGEs (RAGE), triggering chronic inflammatory signalling. Reducing dietary sugar intake reduces both the substrate for AGE formation and the intake of preformed dietary AGEs found in processed and heavily cooked foods.

10. Fish and Omega-3s: Cardiovascular Protection

Fish consumption, particularly of fatty fish rich in long-chain omega-3 polyunsaturated fatty acids (EPA and DHA), is one of the most consistent dietary predictors of reduced cardiovascular mortality in the epidemiological literature.

The Epidemiological Evidence

A 2006 meta-analysis by Mozaffarian and Rimm in JAMA reviewed data from multiple prospective cohort studies and estimated that consuming 1 to 2 servings of fish per week (particularly fatty fish) was associated with a 36% reduction in coronary heart disease mortality (RR 0.64, 95% CI 0.46 to 0.89). They estimated that approximately 250 mg per day of EPA and DHA (the amount provided by 1 to 2 servings of fatty fish per week) was sufficient to achieve substantial cardiovascular protection.

The VITAL study (Manson et al., New England Journal of Medicine, 2019) was a large randomised controlled trial of 25,871 US adults that tested omega-3 fatty acid supplementation (1 gram per day of fish oil providing 840 mg of EPA and DHA) versus placebo for a median of 5.3 years. The primary composite cardiovascular endpoint was not significantly reduced in the overall study population (HR 0.92, 95% CI 0.80 to 1.06). However, important subgroup analyses revealed significant benefits. Among participants with low fish intake (less than 1.5 servings per week), omega-3 supplementation reduced the primary endpoint by 19%. Total myocardial infarction was reduced by 28% in the overall population (HR 0.72, 95% CI 0.59 to 0.90). Among African Americans, the cardiovascular event reduction was 77% (HR 0.23, 95% CI 0.11 to 0.47), an extraordinarily large effect that requires replication but is noteworthy.

The REDUCE-IT trial (Bhatt et al., New England Journal of Medicine, 2019) tested high-dose icosapent ethyl (a purified form of EPA, at 4 grams per day) in 8,179 patients with elevated triglycerides who were already on statin therapy. The treatment group had a 25% relative risk reduction in the primary composite cardiovascular endpoint (HR 0.75, 95% CI 0.68 to 0.83) and a 20% reduction in cardiovascular death (HR 0.80, 95% CI 0.66 to 0.98). This was a landmark trial demonstrating that at pharmacological doses, omega-3 fatty acids can provide robust cardiovascular protection, though the dose used (4g/day) far exceeds what most people would obtain from diet alone.

Beyond Cardiovascular Protection

Fish consumption has also been associated with reduced risk of age-related cognitive decline and dementia. A 2016 meta-analysis by Zhang et al. in the Journal of Alzheimer's Disease found that each additional serving of fish per week was associated with a 7% reduction in dementia risk (RR 0.93, 95% CI 0.90 to 0.95) and a 13% reduction per weekly serving in Alzheimer's disease risk (RR 0.87, 95% CI 0.81 to 0.93). The DHA in fish is a major structural component of brain cell membranes and plays critical roles in neuronal signalling, anti-inflammatory pathways, and synaptic plasticity.

The Omega-3 Index, which measures the percentage of EPA and DHA in red blood cell membranes, has been proposed as a biomarker of cardiovascular risk. A 2018 meta-analysis by Harris and von Schacky found that an Omega-3 Index above 8% (achievable with regular fatty fish consumption or supplementation) was associated with a 35% lower risk of death from coronary heart disease compared to an index below 4%.

11. Nuts: Small Packages, Big Impact

Nuts are one of the most consistently protective foods in the longevity research literature. Despite being energy-dense (typically 550 to 700 calories per 100 grams), regular nut consumption is associated not with weight gain but with reduced mortality, reduced cardiovascular disease, and improved metabolic health.

The Harvard Cohort Data

The landmark study on nuts and mortality was published by Bao et al. in the New England Journal of Medicine in 2013. This analysis used data from the Nurses' Health Study (76,464 women) and the Health Professionals Follow-up Study (42,498 men), with follow-up of up to 30 years during which 16,200 women and 11,229 men died. The results were clear and dose-dependent. Compared to those who never or almost never ate nuts, those who consumed nuts 7 or more times per week had a 20% lower risk of all-cause mortality (HR 0.80, 95% CI 0.73 to 0.86). Those who consumed nuts 5 to 6 times per week had an 15% lower risk. Those who consumed nuts 2 to 4 times per week had a 13% lower risk. Even consuming nuts less than once per week was associated with a 7% lower risk.

The mortality reduction was driven by significant reductions in death from cancer (11% lower), heart disease (29% lower), and respiratory disease (24% lower). The inverse association was observed for all major nut types (peanuts, tree nuts, walnuts) and was consistent across subgroups defined by age, BMI, smoking status, alcohol intake, physical activity, and other dietary factors.

PREDIMED Nut Findings

The PREDIMED trial provided randomised evidence supporting the observational data. The Mediterranean diet group supplemented with 30 grams per day of mixed nuts (walnuts, almonds, hazelnuts) showed a 28% reduction in cardiovascular events (HR 0.72, 95% CI 0.54 to 0.95). A PREDIMED substudy on nut consumption and mortality (Guasch-Ferre et al., BMC Medicine, 2013) found that participants consuming more than 3 servings of nuts per week had a 39% lower risk of all-cause mortality (HR 0.61, 95% CI 0.45 to 0.83) compared to non-consumers. Walnut consumption of more than 3 servings per week was associated with a 45% lower risk of cardiovascular death.

Mechanisms of Protection

Nuts are nutrient-dense packages containing unsaturated fatty acids (both monounsaturated and polyunsaturated, including alpha-linolenic acid in walnuts), plant protein, fibre, vitamins (E, folate), minerals (magnesium, potassium, copper), phytosterols, and a diverse array of polyphenolic compounds. These components work synergistically to lower LDL cholesterol, reduce inflammation, improve endothelial function, reduce oxidative stress, and modulate the gut microbiome. The fibre and protein in nuts also promote satiety, which may explain why regular nut consumption is not associated with weight gain despite the high caloric density. Clinical trials consistently show that adding nuts to the diet does not lead to the expected weight gain based on the calories consumed, likely because of incomplete energy absorption (some calories in nuts are not digested), increased energy expenditure, and appetite suppression.

A practical daily dose supported by the evidence is 30 grams (approximately a small handful), which provides roughly 180 to 200 calories. This amount is consistent with the PREDIMED supplementation dose and falls within the range associated with maximum benefit in the observational studies.

12. Fibre: The Forgotten Longevity Nutrient

Dietary fibre may be the single most underappreciated nutrient in terms of its impact on longevity. Despite receiving far less attention than protein, fat, or individual micronutrients, fibre has one of the most consistent dose-response relationships with mortality of any dietary component.

The Lancet Meta-Analysis

The definitive analysis of fibre and health outcomes was published by Reynolds et al. in the Lancet in 2019. This was a systematic review and meta-analysis commissioned by the World Health Organisation, which included 185 prospective studies and 58 clinical trials involving over 135 million person-years of data. The findings were striking in their consistency and magnitude.

For every 8-gram per day increase in dietary fibre, all-cause mortality decreased by 5 to 27% across the studies reviewed. The dose-response relationship was approximately linear: each additional 10 grams of fibre per day was associated with a 10% reduction in all-cause mortality (RR 0.90, 95% CI 0.86 to 0.94). The benefits extended to specific causes of death and disease. Each 10g/day increase in fibre was associated with a 17% reduction in colorectal cancer (RR 0.83, 95% CI 0.78 to 0.89), a 22% reduction in type 2 diabetes incidence (RR 0.78, 95% CI 0.73 to 0.82), a 30% reduction in coronary heart disease mortality (RR 0.70, 95% CI 0.62 to 0.78), and a 24% reduction in stroke incidence (RR 0.76, 95% CI 0.69 to 0.83).

The optimal fibre intake appeared to be in the range of 25 to 35 grams per day, with benefits continuing up to at least 30 grams per day. Most Western populations consume far less. The average fibre intake in the United Kingdom is approximately 18 grams per day. In the United States, it is approximately 15 grams per day. This means most people are leaving a substantial mortality reduction on the table simply by not eating enough fibre-rich foods.

Types of Fibre and Their Effects

Fibre is not a single substance but a family of complex carbohydrates that resist digestion in the small intestine. Soluble fibre (found in oats, barley, legumes, fruits, and some vegetables) forms a gel in the gut that slows glucose absorption, reduces LDL cholesterol, and provides substrate for beneficial gut bacteria. Insoluble fibre (found in whole wheat, bran, vegetables, and nuts) adds bulk to stool, speeds transit time through the colon, and reduces exposure of the colonic epithelium to potential carcinogens. Resistant starch (found in cooked and cooled potatoes, legumes, and green bananas) functions similarly to fibre and is a potent prebiotic.

Both soluble and insoluble fibre contribute to the mortality benefits observed in the epidemiological literature, though through partially different mechanisms. The gut microbiome fermentation of soluble fibre and resistant starch produces short-chain fatty acids (butyrate, propionate, acetate), which have powerful anti-inflammatory, anti-carcinogenic, and metabolically beneficial effects. We will discuss this further in the microbiome section.

Whole Grains: The Fibre Delivery Vehicle

Whole grains are the largest source of fibre in most diets and have their own impressive mortality data. A 2016 meta-analysis by Aune et al. in the BMJ pooled data from 45 prospective cohort studies and found that each 90-gram per day increase in whole grain consumption (approximately 3 servings) was associated with a 17% reduction in all-cause mortality (RR 0.83, 95% CI 0.77 to 0.90), a 22% reduction in cardiovascular disease mortality (RR 0.78, 95% CI 0.73 to 0.85), and a 15% reduction in cancer mortality (RR 0.85, 95% CI 0.80 to 0.91). These are large effect sizes for a single food group.

13. Specific Longevity Foods: Berries, Olive Oil, Legumes, Green Tea

Beyond broad dietary patterns, certain individual foods have accumulated enough evidence to merit specific discussion as longevity-promoting foods.

Extra Virgin Olive Oil

Extra virgin olive oil (EVOO) is arguably the single food with the strongest direct link to longevity. Beyond its role in the Mediterranean diet, EVOO has been studied independently. A 2022 prospective cohort study by Guasch-Ferre et al. in the Journal of the American College of Cardiology followed 60,582 women and 31,801 men for up to 28 years. Consuming more than 0.5 tablespoons (approximately 7 grams) of olive oil per day was associated with a 19% lower risk of cardiovascular mortality (HR 0.81, 95% CI 0.75 to 0.87), a 17% lower risk of cancer mortality, a 29% lower risk of neurodegenerative mortality, and an 18% lower risk of respiratory mortality compared to those who rarely or never consumed olive oil. Replacing 10 grams per day of margarine, butter, mayonnaise, or dairy fat with olive oil was associated with 8 to 34% lower risk of all-cause and cause-specific mortality.

The unique benefits of EVOO appear to be driven by its polyphenol content, particularly oleocanthal (which has ibuprofen-like anti-inflammatory properties) and hydroxytyrosol (a potent antioxidant). These compounds are present in extra virgin olive oil but not in refined olive oil, which underscores the importance of the "extra virgin" designation.

Berries

Berries (blueberries, strawberries, raspberries, blackberries) are among the most antioxidant-rich foods in the human diet, owing to their high concentration of anthocyanins, ellagic acid, resveratrol, and other polyphenolic compounds. A 2013 study by Cassidy et al. in Circulation found that consuming 3 or more servings of blueberries and strawberries per week was associated with a 34% lower risk of myocardial infarction (HR 0.66, 95% CI 0.44 to 0.97) in a cohort of 93,600 women from the Nurses' Health Study II. The effect was attributed to anthocyanin intake, which was independently associated with reduced heart attack risk after adjusting for other dietary factors.

Berry consumption has also been associated with reduced cognitive decline. The Nurses' Health Study found that women who consumed 2 or more servings of blueberries per week had significantly slower rates of cognitive decline compared to those who consumed none, equivalent to delaying cognitive ageing by up to 2.5 years (Devore et al., Annals of Neurology, 2012).

Legumes

Legumes (beans, lentils, chickpeas, peas) are a dietary staple in all five Blue Zones and have impressive longevity data. A 2004 study by Darmadi-Blackberry et al. in the Asia Pacific Journal of Clinical Nutrition analysed data from the FHILL (Food Habits in Later Life) study of elderly individuals in Japan, Sweden, Greece, and Australia. Legume consumption was the single most protective food group identified, with each 20-gram increase in daily intake associated with a 7 to 8% reduction in mortality (HR 0.92 per 20g/day). This association was consistent across all four cultural groups studied.

The 2022 modelling study by Fadnes et al. found that increasing legume consumption from typical Western levels (approximately 0 to 15 grams per day) to optimal levels (200 grams per day) was associated with the largest lifespan gain of any single food group change: approximately 2.2 additional years of life expectancy for men and 2.5 years for women when the change was made at age 20.

Green Tea

Green tea consumption has been extensively studied in Asian populations and is consistently associated with reduced mortality. A 2020 study by Wang et al. in the European Journal of Preventive Cardiology followed 100,902 Chinese adults for a median of 7.3 years. Habitual tea consumers (those who drank tea 3 or more times per week) had a 15% lower risk of all-cause mortality (HR 0.85, 95% CI 0.79 to 0.90) and a 20% lower risk of cardiovascular mortality (HR 0.80, 95% CI 0.71 to 0.90) compared to those who never or rarely drank tea. The estimated life expectancy at age 50 was 1.26 years longer for habitual tea drinkers. The benefits were stronger for green tea than for black tea, and were more pronounced in men.

The active compounds in green tea include catechins (particularly epigallocatechin gallate, or EGCG), L-theanine, and caffeine. EGCG has demonstrated anti-inflammatory, antioxidant, anti-carcinogenic, and cardioprotective properties in both in vitro and animal studies. The combination of these compounds appears to reduce oxidative stress, improve endothelial function, reduce LDL oxidation, and enhance insulin sensitivity.

14. A Brief Note on Alcohol

Alcohol and longevity is a complex topic that we cover in depth in our separate article on substances and lifespan. Here we will note only the key dietary context.

The traditional observation that moderate drinkers live longer than abstainers has been substantially challenged by methodological critiques. Stockwell et al. (2016) and subsequent analyses have shown that many studies comparing moderate drinkers to abstainers were biased by the inclusion of "sick quitters" (former drinkers who stopped due to illness) in the abstainer category, artificially inflating the apparent mortality of non-drinking. When studies correct for this bias and use lifetime abstainers as the reference group, the apparent protective effect of moderate drinking is substantially attenuated or eliminated.

The Global Burden of Disease Alcohol Collaborators (2018), analysing data from 195 countries, concluded that the level of alcohol consumption that minimises total health loss is zero. Even small amounts of alcohol increase the risk of several cancers (breast, colorectal, oral cavity, oesophageal), and these risks offset any potential cardiovascular benefit. That said, there is some evidence that the pattern of drinking matters: alcohol consumed with meals (as in the traditional Mediterranean pattern) may be less harmful than alcohol consumed separately, possibly because food slows absorption and reduces peak blood alcohol levels. For a complete treatment of the alcohol evidence, please see our dedicated article.

15. The Microbiome Connection to Longevity

The human gut microbiome, comprising trillions of bacteria, archaea, fungi, and viruses, has emerged as a critical mediator of the relationship between diet and longevity. The foods you eat do not merely nourish your own cells; they also feed and shape the microbial ecosystem in your gut, which in turn produces metabolites that influence inflammation, immune function, metabolism, brain function, and biological ageing.

Centenarian Microbiomes

Several studies have characterised the gut microbiomes of exceptionally long-lived individuals. A 2021 study by Sato et al. in Nature found that Japanese centenarians (average age 107) harboured a unique bile acid profile produced by enriched populations of bacteria from the genus Odoribacteraceae. These bacteria produced a secondary bile acid called isoalloLCA, which has potent antimicrobial properties against pathogenic bacteria (including Clostridioides difficile) and anti-inflammatory effects. The authors proposed that this microbial capability may contribute to the reduced infectious disease burden and lower inflammation observed in centenarians.

An earlier study by Biagi et al. in Current Biology (2016) found that Italian centenarians and semi-supercentenarians (aged 105 to 109) had distinct microbial signatures characterised by enrichment of health-associated species such as Akkermansia muciniphila, Bifidobacterium, and Christensenellaceae. These species have been independently associated with lean body composition, reduced inflammation, and improved metabolic health in other research.

How Diet Shapes the Longevity Microbiome

Diet is the single most powerful modulator of gut microbiome composition. A 2019 study by Zmora et al. in Cell demonstrated that dietary changes can reshape the microbiome within days. The key dietary factors that promote a longevity-associated microbiome include the following.

Fibre and fermentable carbohydrates serve as the primary fuel for beneficial gut bacteria. When bacteria ferment fibre, they produce short-chain fatty acids (SCFAs), particularly butyrate, propionate, and acetate. Butyrate is the primary energy source for colonocytes (colon cells), strengthens the gut barrier, reduces intestinal inflammation, and has anti-carcinogenic properties. Propionate regulates hepatic lipogenesis and gluconeogenesis. Acetate influences appetite regulation and systemic inflammation. A diet low in fibre starves these beneficial bacteria and promotes the expansion of mucus-degrading species that can compromise the gut barrier, leading to increased translocation of bacterial products (endotoxin) into the bloodstream and chronic low-grade inflammation.

Dietary diversity is also critical. The more diverse your diet in terms of plant species consumed, the more diverse your microbiome. The American Gut Project (McDonald et al., mSystems, 2018), which analysed microbiome samples from over 10,000 participants, found that the number of unique plant species consumed per week was the strongest predictor of microbiome diversity, more predictive than any other lifestyle or dietary factor. Participants who consumed 30 or more distinct plant species per week had significantly more diverse microbiomes than those who consumed 10 or fewer.

Fermented foods (yoghurt, kefir, sauerkraut, kimchi, miso, tempeh, kombucha) introduce beneficial live microorganisms into the gut. A 2021 randomised controlled trial by Wastyk et al. in Cell found that a high-fermented-food diet (6 servings per day for 10 weeks) significantly increased microbial diversity and reduced markers of systemic inflammation (including interleukin-6), while a high-fibre diet increased microbial fibre-processing capacity without significantly altering diversity in the short term.

Polyphenols, found abundantly in berries, tea, coffee, cocoa, red wine, and olive oil, are metabolised by gut bacteria into bioactive compounds with anti-inflammatory and antioxidant properties. Polyphenols also selectively promote the growth of beneficial species such as Bifidobacterium and Lactobacillus while inhibiting pathogenic species.

The Gut-Brain Axis and Cognitive Longevity

The gut-brain axis, a bidirectional communication network linking the gut microbiome to brain function via the vagus nerve, immune signalling, and microbial metabolites, is increasingly recognised as relevant to cognitive ageing. Gut-derived metabolites such as SCFAs can cross the blood-brain barrier and influence neuroinflammation, microglial function, and neurogenesis. Dysbiosis (an unhealthy shift in microbiome composition) has been associated with increased risk of Alzheimer's disease, Parkinson's disease, and depression. Diets that promote a healthy microbiome (rich in fibre, fermented foods, and polyphenols) may therefore contribute to cognitive longevity in addition to physical longevity.

16. Supplements: What Works and What Is Waste

The global dietary supplement industry is worth over $150 billion annually, and the longevity and anti-ageing segment is among the fastest growing. The appeal is obvious: a pill that could extend lifespan without requiring the effort of dietary change. The reality, however, is that most supplements have failed to demonstrate longevity benefits in rigorous randomised controlled trials, and some may be harmful.

Multivitamins: No Mortality Benefit

The largest randomised trial of multivitamins and mortality is the Physicians' Health Study II (Sesso et al., Journal of the American Medical Association, 2012), which randomised 14,641 male physicians to a daily multivitamin or placebo for a median of 11.2 years. There was no significant effect on all-cause mortality (HR 0.94, 95% CI 0.88 to 1.02), cardiovascular mortality (HR 0.95, 95% CI 0.83 to 1.09), or cancer mortality (HR 0.88, 95% CI 0.77 to 1.01). A modest reduction in total cancer incidence (8%, HR 0.92, 95% CI 0.86 to 0.998) was observed, but this was borderline and has not been consistently replicated.

A 2022 meta-analysis by Luo et al. pooled data from 8 randomised trials involving over 100,000 participants and concluded that multivitamin supplementation had no significant effect on all-cause mortality (RR 0.98, 95% CI 0.94 to 1.02). The evidence is clear: multivitamins do not extend lifespan for the general population.

Vitamin D: Benefits If Deficient

Vitamin D is the supplement with the most nuanced evidence. Observational studies consistently show that low vitamin D levels (below 50 nmol/L or 20 ng/mL) are associated with increased all-cause mortality, cardiovascular disease, cancer, and cognitive decline. However, the critical question is whether supplementation corrects this risk or whether low vitamin D is merely a marker of poor health (confounding by illness, inactivity, and obesity).

The largest vitamin D supplementation trial, VITAL (Manson et al., New England Journal of Medicine, 2019), randomised 25,871 adults to vitamin D3 (2,000 IU per day) or placebo for 5.3 years. There was no significant reduction in the primary endpoints of cancer incidence or cardiovascular events. However, a significant 25% reduction in cancer mortality emerged after the first 2 years (HR 0.75, 95% CI 0.59 to 0.96), suggesting that vitamin D may slow cancer progression rather than prevent initiation. Additionally, subgroup analyses suggested benefits were concentrated in those with low baseline vitamin D levels and in individuals with normal BMI (obesity impairs vitamin D metabolism).

A 2023 individual participant data meta-analysis by Barbarawi et al. in JAMA Network Open pooled data from 44 randomised trials (over 100,000 participants) and found a modest but significant reduction in cancer mortality with vitamin D supplementation (RR 0.93, 95% CI 0.88 to 0.99) but no effect on all-cause mortality. The practical recommendation: test your vitamin D level. If deficient (below 50 nmol/L), supplementation is warranted. If already sufficient, supplementation provides no additional longevity benefit.

Omega-3 Supplements: Modest Cardiovascular Benefit

As discussed in the fish section, omega-3 fatty acid supplementation has demonstrated cardiovascular benefits in large RCTs, particularly at higher doses and in individuals with low dietary fish intake. The VITAL trial found a 28% reduction in heart attacks with 1 gram per day of fish oil. The REDUCE-IT trial found a 25% reduction in cardiovascular events with 4 grams per day of icosapent ethyl. For individuals who do not regularly eat fatty fish, omega-3 supplementation appears to be one of the few supplements with genuine protective evidence.

Vitamin E and Beta-Carotene: Potentially Harmful

High-dose vitamin E supplementation has been tested in multiple large trials and found to be ineffective or harmful. The ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention) trial found that beta-carotene supplementation increased lung cancer incidence by 18% in male smokers. The CARET (Beta-Carotene and Retinol Efficacy Trial) found a 28% increase in lung cancer and a 17% increase in all-cause mortality with beta-carotene and retinol supplementation in smokers and asbestos-exposed workers. The SELECT trial (Selenium and Vitamin E Cancer Prevention Trial) found that vitamin E supplementation (400 IU per day) increased prostate cancer risk by 17% (HR 1.17, 95% CI 1.004 to 1.36). These findings are a sobering reminder that isolated nutrients in supplement form can behave very differently from the same nutrients consumed as part of whole foods.

Emerging Supplements: Cautious Optimism

Several supplements are generating interest in the longevity research community but lack sufficient human RCT data to make definitive recommendations. These include magnesium (observational data suggests inverse association with mortality; many populations are deficient), creatine (emerging evidence for cognitive protection in older adults), collagen peptides (potential benefits for joint and skin health but no mortality data), probiotics (strain-specific benefits for gut health but no mortality data), and NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) (exciting animal data showing lifespan extension but no human longevity data yet).

17. How Death Clock Uses Diet Data

Death Clock integrates dietary information into its lifespan estimation model because the evidence reviewed in this article demonstrates that diet is one of the most impactful modifiable factors influencing human longevity. When you complete the Death Clock quiz, your responses about dietary patterns directly influence your estimated lifespan.

The model accounts for several dietary dimensions. Overall dietary pattern is assessed because the research consistently shows that the totality of your diet matters more than any individual food or nutrient. A Mediterranean-style pattern rich in vegetables, fruits, whole grains, legumes, nuts, fish, and olive oil is associated with the greatest longevity benefit, adding an estimated 4 to 5 years to life expectancy at high adherence levels. Conversely, a diet dominated by ultra-processed foods, red and processed meat, and added sugar is associated with significantly shortened lifespan.

Fruit and vegetable consumption is weighted because of the robust dose-response relationship between plant food intake and reduced mortality. The WHO estimates that low fruit and vegetable consumption is responsible for approximately 3.9 million deaths worldwide per year. Each additional serving of fruit and vegetables per day is associated with a roughly 5% reduction in all-cause mortality, up to approximately 5 servings per day, after which the benefit plateaus (Aune et al., International Journal of Epidemiology, 2017; 95 cohort studies, 2 million participants).

Processed meat and ultra-processed food consumption is penalised in the model because these food categories have the most consistent associations with increased mortality. The dose-response data from the studies described in this article (18% increased colorectal cancer risk per 50g/day of processed meat; 14% increased mortality per 10 percentage point increase in UPF consumption) are incorporated into the risk calculations.

The Death Clock model does not prescribe a single "correct" diet. It recognises that multiple dietary patterns (Mediterranean, plant-based, pescatarian, and traditional whole-food diets from various cultures) are associated with longevity, and it adjusts life expectancy estimates based on how closely your reported diet aligns with the patterns supported by the strongest evidence.

By providing a personalised estimate of how dietary choices affect your projected lifespan, Death Clock aims to make the abstract population-level statistics in this article concrete and personal. Knowing that the Mediterranean diet adds "4 to 5 years on average" is informative; seeing how your specific dietary pattern affects your individual projection is motivating.

18. Putting It All Together: A Practical Longevity Plate

The research reviewed in this article spans millions of participants, decades of follow-up, and dozens of countries. Despite the complexity, the findings converge on a remarkably consistent set of dietary principles. Here is what a longevity-optimised diet looks like in practice.

The Foundation: Plants, Whole Foods, Minimal Processing

The single most impactful dietary change most people in industrialised countries can make is to shift the balance of their diet from ultra-processed foods towards whole, minimally processed foods, with an emphasis on plant-based ingredients. This does not necessarily mean becoming vegetarian or vegan, though both patterns are associated with longevity when done well. It means making vegetables, fruits, whole grains, legumes, nuts, seeds, and healthy oils the foundation of most meals, with animal products (if consumed) serving as complements rather than centrepieces.

Daily Non-Negotiables (Supported by the Strongest Evidence)

Based on the evidence reviewed in this article, the following daily dietary practices have the most robust support for extending lifespan. First, consume at least 5 servings of vegetables and fruits per day (the dose-response relationship shows maximum benefit around 800 grams per day, but the steepest mortality reduction occurs between 0 and 5 servings). Second, consume 25 to 35 grams of fibre per day from whole grains, legumes, vegetables, fruits, and nuts. Third, consume extra virgin olive oil as the primary cooking and dressing fat (at least 1 tablespoon per day). Fourth, eat a handful of nuts (approximately 30 grams) daily. Fifth, include legumes (beans, lentils, chickpeas) in at least one meal most days. Sixth, eat fatty fish at least twice per week (salmon, mackerel, sardines, herring). Seventh, drink green tea or other polyphenol-rich beverages.

Weekly Priorities

On a weekly basis, the evidence supports consuming a wide diversity of plant species (aim for 30 or more unique plant species per week to promote microbiome diversity), including fermented foods regularly (yoghurt, kefir, sauerkraut, kimchi), consuming whole grains at most meals (oats, brown rice, quinoa, whole wheat, barley, rye), and limiting red meat to 2 to 3 servings per week at most, prioritising unprocessed forms and smaller portion sizes.

What to Minimise or Avoid

The evidence is equally clear about what to reduce. Processed meat should be minimised as much as possible (the evidence shows harm at any regular level of consumption). Sugar-sweetened beverages should be eliminated or nearly so (the dose-response data shows no safe level of regular consumption). Ultra-processed foods should be reduced to the greatest extent practical (aim to keep UPFs below 20% of total caloric intake, versus the current 50 to 60% average in most Western countries). Added sugar should be kept below 5 to 10% of total caloric intake, consistent with WHO guidelines. Refined grains (white bread, white rice, white pasta) should be replaced with whole grain alternatives.

The Fadnes Model: Quantifying the Gains

The 2022 Fadnes et al. study in PLOS Medicine modelled the cumulative lifespan gains from shifting from a typical Western diet to an optimal diet. The results provide a useful framework for prioritisation.

The message is both humbling and empowering. Diet is not a minor lifestyle factor. It is, according to the modelling data, potentially the single most impactful modifiable determinant of lifespan, with gains that rival or exceed those from eliminating smoking, regular exercise, or any available pharmaceutical intervention. And unlike many longevity interventions, dietary change is available to everyone, requires no prescription, and can begin immediately.

A Note on Perfection Versus Consistency

One of the most important practical lessons from the longevity diet literature is that consistency matters far more than perfection. The dose-response curves for most dietary factors show the steepest benefits at the initial stages of improvement. Moving from a highly processed, low-fibre, low-vegetable diet to a moderately healthy diet captures most of the mortality benefit. The additional gain from moving from "pretty good" to "perfect" is marginal by comparison. This is liberating. You do not need to adopt a strict, restrictive dietary regimen to gain substantial longevity benefits. You need to make the big, high-impact changes (more vegetables, more fibre, more legumes and nuts, less processed meat and ultra-processed food) and sustain them over time. The best longevity diet is the one you will actually follow for the rest of your life.

19. Full Reference Table

The following table lists the major studies cited in this article, organised by topic, for readers who wish to explore the primary literature.

Related Articles